ReviewThe Journal of dermatology2024

Risk of multiple sclerosis in patients with psoriasis receiving anti-IL-17 agents: A case-based review.

Sotirios G Tsiogkas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.